850 shares of HealthEquity, Inc. (NASDAQ:HQY) acquired by Point72 Asia Singapore Pte. Ltd.

Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 850 shares of the company’s stock, valued at approximately $73,000.

A number of other hedge funds and other institutional investors have recently modified their holdings of the company. Truist Financial Corp grew its position in HealthEquity by 7.0% in the second quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after buying an additional 188 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its holdings in shares of HealthEquity by 3.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock valued at $426,000 after purchasing an additional 197 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of HealthEquity by 7.5% in the second quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock valued at $246,000 after acquiring an additional 198 shares in the last quarter. Campbell & CO Investment Adviser LLC raised its position in HealthEquity by 3.2% in the fourth quarter. Campbell & CO Investment Adviser LLC now owns 8,195 shares of the company’s stock worth $543,000 after purchasing an additional 254 shares in the last quarter. Finally, CWM LLC boosted its stake in HealthEquity by 6.9% in the second quarter. CWM LLC now owns 3,958 shares of the company’s stock worth $341,000 after acquiring an additional 255 shares during the last quarter. 99.55% of shares are held by hedge funds and other institutional investors.

HealthEquity trading up 6.3%

HQY opened at $83.09 on Friday. The firm has a market cap of $7.23 billion, a price-to-earnings ratio of 90.32, a PEG ratio of 1.25 and a beta of 0.52. The stock has a fifty day moving average price of $76.47 and a 200 day moving average price of $79.20. HealthEquity, Inc. it has a 12-month low of $61.81 and a 12-month high of $88.26. The company has a current ratio of 4.10, a quick ratio of 4.10, and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY – Get Free Report ) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.25 earnings per share for the current fiscal year.

Analysts set new price targets

Several equities research analysts recently issued reports on HQY shares. JMP Securities reaffirmed a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Raymond James upped their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Bank of America reduced their price objective on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, September 4th. Barrington Research restated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a report on Friday, September 20th. Finally, Wells Fargo & Company boosted their target price on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a report on Thursday, June 20th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $103.83.

Get the latest analysis on HQY

Insider activity at HealthEquity

In related news, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the transaction, the director now owns 6,070 shares of the company’s stock, valued at $497,072.30. This trade represents a decrease of 0.00 % in the stock holding. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Director Frank Corvino sold 7,705 shares of the stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the sale, the director now directly owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. This represents a 0.00 % decrease in ownership of the shares. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the transaction, the insider now owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. This trade represents a 0.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,952 shares of company stock valued at $3,526,147 over the last quarter. Insiders own 2.20% of the company’s shares.

HealthEquity profile

(Free report)

HealthEquity, Inc provides technology-based service platforms to consumers and employers in the United States. The company provides cloud-based platforms for individuals to make health savings and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings and make investment choices ; and health savings accounts.

Read more

Want to see what other hedge funds own HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for HealthEquity, Inc. (NASDAQ:HQY – Free Report).

Get news and reviews for HealthEquity Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for HealthEquity and related companies with MarketBeat.com’s FREE daily email newsletter.